TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991